Decentralized Clinical Trials Promised Faster Recruitment. The Evidence on Actual Performance Is In.
Dr. Dereck Mush, MD, MBA
What they do
Inato operates a marketplace platform that matches pharmaceutical sponsors with verified community clinical trial sites worldwide. By unlocking access to diverse, underrepresented patient populations, the platform helps sponsors accelerate recruitment and ensure equity in research.
The record
- Vertical
- Clinical Trials
- Sub-segment
- Patient recruitment
- Product type
- Marketplace
- Stage
- Series B
- Headquarters
- Paris, France
- Region
- Europe
- Founded
- 2016
- Total funding
- $33M raised
Notable investors: Obvious Ventures, Cathay Innovation, Serena, Fly Ventures.
Also in Clinical Trials
Related on The Signal
Dr. Dereck Mush, MD, MBA
Unlocking Orphan Neuromuscular Indications: Why IntraBio's Aqneursa Approval Signals a Regulatory Re-evaluation of Small-Cohort Crossover Trials
Dr. Dereck Mush, MD, MBA
Decentralized and adaptive trial designs move from pilot to default in biotech development plans
Dr. Dereck Mush, MD, MBA
Inside SURPASS: ARPA-H's Bid to Redesign Clinical Trials
Dr. Dereck Mush, MD, MBA